Health / Health News

    Researchers identify compounds that could lead to an on-demand, short-term contraceptive for men

    In a mouse study, researchers have identified a potential non-hormonal contraceptive that men could take shortly before sexual activity and have fertility restored the next day.



    Researchers identify compounds that could lead to an on-demand, short-term contraceptive for men. Photo: NIH


    Researchers gave male mice a compound that temporarily disables soluble adenylyl cyclase, the enzyme essential for activating a sperm cell’s ability to swim and mature so that it can travel through the female reproductive tract and fertilize an egg.

    In several tests, the researchers showed that the compound TDI-11861 rendered mouse sperm cells immobile and prevented them from maturing.

    The compounds did not interfere with the animals’ sexual functioning.

    Although male mice mated with females, no pregnancies were observed. Sperm recovered from female mice remained incapacitated.

    The authors did not observe any side effects in the male or female mice. The compound wore off three hours later, and males recovered their fertility.

    The study was conducted by Melanie Balbach, Ph.D., a postdoctoral fellow in the laboratories of coauthors Jochen Buck, Ph.D., and Lonnie Levin, Ph.D., at Weill Cornell Medical College, New York City, and colleagues.

    The researchers say their work provides proof of concept that soluble adenylyl cyclase inhibitors have the potential to provide a safe, on-demand, non-hormonal and reversible oral contraceptive for men. (National Institutes of Health)

    FEBRUARY 15, 2023



    YOU MAY ALSO LIKE

    Researchers have found differences in the gut microbiomes of people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) compared to healthy controls.
    Cambridge scientists have successfully trialled an artificial pancreas for use by patients living with type 2 diabetes.
    New technique enables automatic detection of placental compartments, oxygen status and structural abnormalities.
    Synthetic molecules that adhere cells could galvanize regenerative medicine.
    A promising approach to control Staphylococcus aureus bacterial colonization in people – using a probiotic instead of antibiotics – was safe and highly effective in a Phase 2 clinical trial.
    Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact